Abri Science is a startup coming out of USciences, an institution of higher education, notable as being the nationâs first college of pharmacy. A pediatric rare disease firm, Abri Science is addressing address Phenylketonuria (PKU). This task is being addressed by tackling how to enabling enzymes and catalysts to perform in harsh environments. The formation of the new entity came out of a technology transfer collaboration partnership between Early Charm Ventures, a Baltimore-based startup studio that collaborates with academic researchers to convert science to business; L2C Partners, a Philadelphia-based company that provides outsourced technology transfer and commercialization services for higher education and research-focused institutions and USciences.
